ch iatric disorders. This failure may mean that the processes mediating psychiatric disorders arc beyond 1 he resolution of PET or, alternatively, that the design of PET studies of psychiatric disorders is not sufficiently refined.
The primary focus of PET studies up to the present has been the investigation of neurologic disorders. I n the application of PET to psychiatric research it is important to bear in mind essential differences between psychiatric and neurologic disorder-s. Psychiatric illness involves the disorganization of internal experience as opposed to the breakdown of primary sensorimotor function. Arguably PET methodologic strategies that have proved fruitful in the study of neurologic disorders. where there are fixed pathologic features, may be inappropriate to the study of psychiatric disorders. In psychiatric disorders, with no fixed pathologic features, abnormalities are likely to be "functional,"
involving disturbed neural integration. Therefore novel st.rat.egies or augmentation of existillg methods will be necessary in the investigation of these disorders.
The choice of appropriate PET methods for data acquisition and analysis ill studies of atric disorders has still to be established.
normal responsivuy of psychiatric patientsto chologic and physical stressors makes conditions critical. It can be argued that state metabolic scans should be augmen studies during the performance of cogniti\t or during specific phannacologic manip Most PET studies reponed to dale have quired under resting conditions and thisma tially explain the lack of consistent finding> absence of standardized approaches to PET' analysis in circumstances where little iskno cerning regional pathologic characteristicst hcr drawback and has led to an excess reli ratio data. This type of approach can often leading because such relative values hav shown to be highly sensitive to ambient co The seemingly arbitrary region of interest tion reponed in the literature emphasizes for standardized methods of region of' definition or the exploration of alternan preaches.
As well as issues of study design, eq must be applied to patient selection and ization. Homogeneity of the patient group darnental in psychiatric studies. Lack of neity can render relationships between groups and PET measures extremely elus homogeneity is difficult to achieve using sectional assessments, which are standard ch iatric research. Such methods need lobe mented by either longitudinal assessments use of genetic or other such biologic mark gandremitting nature of many psychiatric emphasizes the need for appropriate studiesin relation to clinical state. , articleexamines finLlings from PET studtientswith psychiau ic and neuropsychiaiers and highlights areas of current and terest, Most studies have concerned the ychiatricdisorders, schizophrenia and afrders, and consequently the greater thisarticle will address findings in these SCHIZOPHRENIA phrenia is the most prevalent and dis-}'choticdisorder and is characterized by age of onset, symplOms such as hallucidelusions, disordered thinking (positive s),and impoverished motivation and feeltivesymptoms e early studies of regional cerebra I blood BF) in schizophrenia using xenon inhalaniques suggested a relative decrease in regions 1 -' Despite rnethodologic probriIh these pioneering studies, associations betweenabnormal patterns of' per-fusion • IC symptoms. l n general, patients with t frontal rCBF tended la be the most ,mute, and indifferent. This pattern of talilYtherefore is a finding antedating remainsimportant and controversial. frontality, a relative reduction in precortical blood now or metabolism, has been ported using PET.' -7 Despite this, there uingcontroversy regarding its reproduciificity, sensitivity to the confounding efrugs,and dependence on cognitive stale s.Three studies lIsing deoxyglucose as lic-tracer, which yielded contradictory rebeconsidered.
DeLisi et al" studied patients with chronic schizophrenia and matched controls. The patients met strict DSM-1I criteria tor schizophrenia and were medication free for at least 2 weeks prior to the study. Patients had significanLly lower anterior to posterior ratios (eight of the nine patients had ratios less than 1). Cerebral atrophy as determined by CAT scan was not associated with this aberrant metabolic pattern. Cur et apuo in two communications described abnormalities of the subcorticoconical metabolic gradient in schizophrenic patients who were medication free for at least a week. The duration of illness varied from 3 lO 17 years. No evidence for hypofrontality was found. Finally, Szechtman et al!' in a controlled study examined whether neuroleptic treatment duration influenced the regional distribution of metabolism in patients meeting Research Diagnostic Criteria (RDC) for schizophrenia.
The patient group was dichotomized according to treatment duration. Both groups had a greater anterior to posr.erior ratio than control subjects, although this was less evident in the group with the longest neuroleptic exposure.
As in much other work on schizophrenia, the basic findings with PET are often not reproduced. Explanations for these apparently inconsistent results include the confounding effects of treatment and illness duration as well as differences in scanning procedure and in image analysis. An important consideration is the relative preponderance of positive and negative symptoms in the groups studied, which may reflect differing etiologies and pathologics. In this context Liddle" has described three subsyndromes of schizophrenia which include a syndrome of "psychomotor poverty" characterized by negative symptoms (Ilat affect, poverty of speech and spontaneous movement), Based on a comparison of signs and symptoms in focal brain lesions, it is suggested that this syndrome is associated with impaired dorsolateral prefrontal conical (DLPFC) function. The prediction that hypofrontality is associated with negative symptoms, within any patient group, has received independent support From PET studies, Dclisi et al 13 may reflect either the role of neuroleptic washout or a prirnir ive dopaminergic depiction as proposed by some authors in the chronic form of schizophrenia."!" This is consistent with a study of patients. characterized by short duration of illness, before and after medication.!" In a medication-free state, patients had asymmetric basal ganglia uptake. left greater than right. Following dopamine recepior blockade consequent upon trcauuem. this asymmetry was abolished. btu a left prefrontal cortical reduction in glucose uptake became evident.
Basal ganglia changes in dopamine pharrnacology have been reponed from postmortem studies of schizophrenia patients, although the Findings arc confounded by possible drug effects. Increase in D2 receptoi s in unmedicated schizophrenic patients has partial support from the PET literature. \Vong et at,"' lIsillg displacement of lie N-rnethylspiperonehy nnlabelcd haloperidol, studied 02 recepior densny in normal, drug-naive, and treatcd schizoplu euic subjects. A three-compartment model with irreversible radioligand binding was assumed. Significant increases in receptors were reponed for both schizophrenic groups, with the increase being more evident in drug-treated patients. There is continuing debate over the reproducibility of these findings20 and criticisms of met hods or data analysis have been expressed."
Making I'ET a behaviorally or pharmaoologically specific technique is the object of activation paradigms.
Bchavioral specificity can be achieved by using PET in conjunction with cognitive or sorimotor activation. Regional deficits measu with PET can be seen as a common concomitant clinical and neuropsychologic symptoms. Ths proach depends on first establishing the fundi anatomy of relevant conical and subcortical gions in normal subjects. Weinbcrger et al 22 reported findings that imply physiologic dys! tion of the prefrontal cortex in response to a cific cognitive challenge, the Wisconsin Card
Using the xenon-133 inhalation technique. reponed that at rest patients had a relative not absolute reduction in dorsolateral prefr now. During the cognitive activation, the pa' showed evidence of impaired augmentation of regional now. These results have yet to be inde dently reproduced, and the likelihood that particular complex task involving a visual.abst and motor component is regionally specifics uoversial.
Other, more simple, activation study d have been reponed. Cohen et al 23 studied ce function during an auditory discrimination designed to emphasize sustained attention. A rcct relationship was found between metabolic in the prefrontal cortex and accuracy of pe mance. In schizophrenics lower flow was foun the prefrontal cortex, which was unrelated to performance. warkcntin et al,~1 again usinga non inhalation measurement of reBF. useda bal fluency task as a cognitive challenge. The marked effect of the activation in normal su was seen in Ihe left prefrontal area, but in schizophrenic group this increase was auenu The investigators conclude, "The controve garding frontal lobe dysfunction in schizoph is related 10 whether these areas are fundi challenged or not." Using 11C-deoxyglucose PET tracer, Volkow et al 25 studied pauents chronic schizophrenia using a smooth pursui tracking activation task. Both at baseline and ing activation, patients displayed absolute an alive frontal hypometabolism.
Patients with live symptoms had lower frontal, temporal. parietal metabolic rates compared with those positive symptoms across both conditions. Si cant between-condition differences were solely in the positive group. During task mance. significant negative correlations frontal lobe metabolism and symptom ratin peared. This study therefore illustrates the that activation studies may increase not on specificity, but also the sensitivity of PET. biology has not been addressed by PET ies of schizophrenia.
Berman
function is for the schizophrenic twin in a discordant hermore, lifetime neuroleptic medication 1 explain differences in hypofrontality in ncordant pairs. This finding, which needs 'on with PET, may suggest that hypofronnotdirectly mediated by the genotype. conclusion, PET studies of schizophrenia a pattern of hypofrontality in some gmups tsdiagnosed as schizophrenic. urememof cerebral blood flow (CRF) and sm, Early studies used the xenon inhalaique.These will be discussed as a prelirna consideration of PET studies.
iesof CBF in affective disorders, using on inhalation technique, have suggested · ed decreases in CRr in depressed paathewet aJ27 studied 13 young patients Age· and sex-matched control group. The metRDC for depression and had a medihour period of 2 weeks. A generalized incerebral blood flow was reponed in the compared with control subjects. An intionship was observed between blood an index of illness severity. The princi·Igswere replicated by a number of separate investigators, who likewise reported decreased CB F in depressed corn pared with control subjects.
.
29 Uytdenhoef et apo reported changes of a different kind in a study of unipolar and bipolar patients, the latter while in remission. Significant left frontal hyperperfusion and right posterior hypoperfusion were seen in the depressive compared with control subjects. This pattern was not observed in the euthymic bipolar patients, suggesting that alterations in rCBF in depression might be state dependent.
These findings were not replicated in a number or other reports. Gustafson et apt compared a heterogeneous group of patients, including dcpressives. with normal controls and failed to find differences across groups. Other studies of depressed and manic subjects 32 and depressed patients alone" failed to find differences from controls.
A single study of depressed patients, using the xenon technique, has used an activation paradigm. Patients were studied in the resting stale and during performance of both a verbal and a spatial task." Although no overall differences were apparent between groups during rest, differences emerged in the rCBF patterns of depressive and control subjects during cognitive activation. The depressed female patients had higher than normal flow in all states, whereas the depressed male patients had lower resting now that became normal during cognitive activation.
The earliest study of affcctivety ill patients using PET compared regional cerebral metabolic rate of glucose (rCMRglu) values in schizophrenic, affective disorder, and control subjects using a somatosensory paradigm (subjects received lIsec electric shocks to the right forearm) which attempted to control for the ambient state across subjeers." The affective patients showed a reduced anteroposterior gradient in glucose metabolism compared with control subjects. The order of magnitude of these changes is indicated by an investigation that demonstrated a similarity in the metabolic rates for glucose between patients with depression and those with multi-infarct dementia.:\6 Only a single report to date has failed to find altered cerebral metabolism in depression."
No differences were found in cerebral glucose utilization in a heterogeneous group of chronic psychiatric patients, including six chronic depressives, and normal control subjects. The srnall sample size and the chronic population studied limit and complicate the interpretation of this study. In contrast to these preliminary reports a detailed series of studies of affective patients using ISF deoxyglucose as a metabolic tracer has been reported.
3x -1u
In the first of these, unipolar and bipolar patients were studied under a variety of con-333 In a subsequent communication on an cnlarged series of patients, including unipolar deprcssives, bipolar depressives, a bipolar mixed group, a manic group, and a control group, the bipolar depressed and the mixed bipolar patients were reported as displaying lower supratentorial whole-brain glucose metabolic rates than any of the comparison groups." Patients with unipolar depression had significantly lower metabolic ratios of caudate nucleus to whole hemisphere values than either the other patient groups or control subjeers. The data further suggested, like the xenon studies, that global hypometabolism in the depressed bipolar patients was state dependent because the metabolic rates "normalized" when patients were euthymic or in a manic phase.
The possibility of a common pathophysiologic basis for the behavioral expression of depression was investigated in a study that examined cerebral me-tabolic rates in a heterogeneous group of depressives, patients with obsessive compulsive disorders with or without major depression, and normal control subjects. 4o A significant lowering of metabolic rates for glucose in the left dorsal anterolateral prefrontal cortex was reported in patients with primary depression, unipolar and bipolar, by comparison with other groups. Similar results, although less marked, were obtained for the right dorsal anterolateral prefrontal cortex. Obsessive compulsive patients with depression displayed lower metabolic values in the same regions as pauerns with primary depression. Glucose metabolic r.ues in the left anterolateral prefrontal cortex correlated significantly with severity ratings of depression. Following clinical response to medication. the metabolic pattern became normal. The investigators concluded that the findings suggested a left anterolateral prefrontal cortex abnormality in major depression.
in conclusion, PET, and early studies using xenon, of affecuvely ill patients are consistent in ing decreased cerebral metabolism, greatest' inferior frontal region, during the depressed No theoretical framework has been articul accommodate these findings with conven theories of monoaminergic Cunction in depr The findings have considerable face validity" mood changes are a frequent concomitant of tal lobe pathologic states. Although the findi decreased frontal metabolism are remini those reponed in schizophrenic patients, the anatomic resolution of early PET techniques not exclude subtle focal differences between nosologically distinct patient groups.
OB SESSIONAL DISORDERS
Obsessional compulsive disorders ( among the most disabling non psychotic psyc disorders and occur in pure form or as phenomena in other psychiatric disorders, ularly depression, and in primary neuro orders. This association with neurologic . and the similarities between intrusive id OCD and intrusive motor acts, such as tics. to the hypothesis that OCD may be secon dysfunction in basal ganglia or related This hypothesis is now amenable to direct by PET.
Baxter et al" compared metabolic glucose in 14 patients with OCD, normal subjects, and patients with primary depr significant increase in the metabolic rate in orbital gyrus, a nonsignificant increase in orbital gyrus. and a bilateral increase in metabolism, specific to patients with observed. Changes in the caudate to he metabolic ratio exclusive to medication-r OeD patients were also reported. In a study, OCD patients with and withou depression were compared with normal subjects. Metabolic rates in the QCD pa .
depression were significantly lower in [he terolateral prefrontal cortex compared \\' patients without depression, a metaboli similar to that seen in patients with depression.
A single study of five pati
Gilles de la Tourene syndrome, a condni invariably associated with obsessional ph has also reported increased metabolism in ganglia.
12
PET studies therefore support the h that obsessional disorders are associated tional changes in the basal ganglia and lobes. Because OCD is responsive to ps, macologic treatment it would be of interblishthe effects such intervenuons might cerebral metabolism. The findings if cswould have a major impact on the nosotus of QeD, which has tradiuonally been as a neurotic disorder with a presumed gicetiology.
XIETY AND PANIC DISORDERS ecurrent, discrete, episodic, and spontanexieryattacks arc the principal features of disorder (PD). Its nosology is controversial generallyis considered as a form of anxiety, gh there is a viewpoint that PD is a sepaosologic enuiy with unique pathophysiologic ensues. A feature of PO is that it may be kedin susceptible patients by sodium lactate 'on.
e relationship between panic disorder and : has been investigated using PET. 13 Cereflow was measured in patients with a , of panic disorder and control subjects.
ups of patients with PD were identified, l', patients with posiuv c and negative lactate . Whole brain and hemispheric CBF was red as well as specific brain regions, include hippocampus and parahippocampal gyrus. differenceswere found between groups for brain or hemispheric CBF, bUL the left LO CBF ratio differed in the parahippocarnpal ofthe lactate responders. In an extension of study,with the addition of further patients PD and control subjects. the finding was repand in addition asyrnmetries of blood volandoxygen metabolism were found. The paiswithPD also had higher whole brain oxygen ism." Therelationship between anxiety, panic disr, and normal anucipatory anxiety was in·gatedin a study 01" subjects at rest and dursodiumlactate infusion." During periods of induced anxiety. there were increases in in the anterior temporal poles, insular (orclaustrum,lateral putamen, the vicinity of the iorcclliculus, and left. anterior cerebellar vcrThere was no increase in rCBF in the non-. and control subjects. A separate study mea-!CBF in subjects while they anticipated a fulelectric shock.":' In these subjects anticipaanxietywas associated with an increase in CBf temporal poles.
Boththese lauer studies suggest a common wayfor the expression of anxiety, involving uresin the temporal poles, and relate well r.o recent conceptualizations of the pathophysiologic basis of anxiety."6 Studies of patients with PD provide intriguing evidence that this condition has a biologic basis separate from generalized anxiety.
NEUROPSYCHIATRIC DISORDERS
Psychiatric morbidity, both psychotic and nonpsychotic, is common in primary neurologic illness. The application of PET r.o the study of such neuropsychiatric disorders should greatly extend our knowledge of brain-bchavior relationships and clarify pathophysiologic mechanisms mediating primary psychiatric disorders. The mechanisms by which focal brain insults result in ncuropsychologic impairment is open to study. Few PET studies, with notable exceptions, have extended their boundaries beyond either a primary ncurologic or psychiatric perspective. A full review of PET in neuropsychiatric disorders is beyond the scope of this article: two studies will be considered as illustrative of the potential application of PET in neuropsychiatric research.
A wide range of clinical manifestat.ions are recognized following isolated infarcts of the thalamus, including verbal and visual mcmory impairment, aphasia, neglect, and behavioral change. A clinicopathologic perspective might suggest that these impairments reflect a critical role for the thalamus in these diverse psychologic functions. However, findings from PET investigations of such patients with thalamic lesions provide a different viewpoint, suggesting that neuropsychologic impairment relates to remote physiologic effects rather than the direct pathologic effects of lesions. Baron et al'? in a comhined PET and ncuropsychologic study of ten patients with single isolated unilateral lesions of the thalamus reponed that nine of ten displayed significant and widespread ipsilateral conical hypometabolism remote from the lesion. These patients also displayed a range of neuropsychologic impairments with a marked trend for deficits LO be related LO degree of conical hypometabolism.
Depression is a common accornpaniment of Parkinson's disease and may frequently antedate the onset of motor impairment.
Its relationship to the disorder is controversial and has been conceptualized as a psychologic reaction to the motor disability. Maybcrg et al-t!lhave investigated the relationship between cerebral glucose metabolism and mood disorder in parkinsonian patients. Depressed parkinsonian patients had a significant decrease in rCMRglu in the orbital and inferior prefrontal cortex compared with nondepressed patients and control subjects. A significant corrc-:335 lation emerged between ratings of mood severity and rCMRglu in these regions. It is tempting to speculate that the decreased metabolism was related to loss of extrastriatal ascending monoaminergic projections, since destruction of these pathways in primates is associated with decreased frontal metabolism.
SUMMARY
PET is potentially the most powerful tool yet available for the direct. in vivo investigation of the biologic basis of psychiatric and neuropsychiatric disorders. The fulfillment of its potential rests on the development of methodologies and study design appropriate to psychiatric disorders. To dale, findings in both schizophrenia and affective disorder, using protocols largely based on resting state data acquisition, suggest altered regional metabolism. These approaches need to be extended, particularly by the application of protocols that utilize PET to obtain longitudinal data under controlled experimental situations.
In two conditions traditionally ascribed to psychologic causes, QeD and PD, there is intriguing evidence of specific biologic abnormalities, which, if confirmed, would lead to a fundamental revision of their nosologic status. In neuropsychiatric disorders PET findings, although preliminary in nature, offer an alternative paradigm to traditional clinicopathologic correlations by suggesting that clinical impairments relate to physiologic effects at sites distant from structural lesions.
